Open AccessCLINICAL AND PHARMACOLOGICAL EVALUATION OF THE INFLUENCE OF DIFFERENT CLINICAL FACTORS ON THE DETERMINED LEVEL OF GLYCATED HEMOGLOBIN IN PATIENTS WITH DIABETES MELLITUS TYPE 2
Author(s) -
A.T. Ahverdiev,
N.F. Nagiev,
R.Yu. Mamedov
Publication year - 2020
Publication title -
evrazijskij soûz učenyh/evrazijskij soûz učënyh
Language(s) - English
Resource type - Journals
eISSN - 2413-9335
pISSN - 2411-6467
DOI - 10.31618/esu.2413-9335.2020.3.73.664
Subject(s) - medicine , glycated hemoglobin , glycemic , type 2 diabetes mellitus , diabetes mellitus , concomitant , type 2 diabetes , endocrinology
With the purpose to determine the prevalence and significance of the influence of various clinical factors on the glycemic control of patients with diabetes mellitus type II, 118 case histories of a therapeutic hospital were analyzed. Analysis of the documentation included the identification of concomitant diseases and conditions, as well as the use of medicines that could directly or indirectly affect the level of HbA1c detected in the patient's blood. In the first case, the presence of such a pathology or condition was revealed in 35 patients (29.7% of the contingent). Moreover, in the 22s they influenced the direction of false understatement, and in 13, on the contrary, its false overestimation. Acceptance of medicines that had significant potential for falsification of the determined level of HbA1c was observed in 39 patients (33.1% of the examined). The quantitative values of the possible analysis error as a result of such influences are discussed. The need for a more thorough analysis of the upcoming course of medicinal therapy for patients with diabetes mellitus type II, including with the participation of a clinical pharmacist (pharmacologist), is indicated.